IFP Advisors, Inc - GENEREX BIOTECHNOLOGY CORP D COM ownership

Back to all holdings Add to watchlist

GENEREX BIOTECHNOLOGY CORP D COM's ticker is GNBT and the CUSIP is 371485301. A total of 1 filers reported holding GENEREX BIOTECHNOLOGY CORP D COM in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of GENEREX BIOTECHNOLOGY CORP D COM
ValueSharesWeighting
Q2 2021$0–0
-100.0%
0.00%–
Q1 2021$0–970
-44.7%
0.00%–
Q4 2020$0
-100.0%
1,755
-93.3%
0.00%–
Q3 2020$7,000–26,352–0.00%–
 Download
Other shareholders
GENEREX BIOTECHNOLOGY CORP D COM shareholders Q1 2021
NameSharesValueWeighting ↓
Coston, McIsaac & Partners 28,572$00.00%
View complete list of GENEREX BIOTECHNOLOGY CORP D COM shareholders